The Cellular Therapy Form was originally designed to collect data on stem cells, progenitors or mature cells, such as T-lymphocytes, unmanipulated, such as DLI, or sorted and/or cultured and/or genetically manipulated, such as CAR T-cells, used for treatment in combination with HSCT or alone, and including advanced therapeutic medicinal products (ATMP), as well as data on the clinical characteristics and患者的结果。它已被修订,主要重点是收集有关治疗患者的CAR-T细胞的数据,并适应了现在部署以支持EBMT注册中心的不断发展的数据。
主要关键词